Table 2.
Group | Inheritance | Phenotypes | Outcomes Observed |
---|---|---|---|
ACTG2:p.Arg178 | De novo or dominant inherited | MMIHS-Most severe neonatal presentation with microcolon | High rates of mortality and transplantation |
ACTG2:p.Arg257 | De novo or dominant inherited | MMIHS or CIPO. Typically Severe neonatal presentation usually without microcolon and more variability | High rates of mortality and transplantation |
ACTG2:p.Arg40 | De novo or dominant inherited | MMIHS or CIPO. Severity range and more moderate or mild cases than groups above | Moderate to high rates of mortality and transplantation |
ACTG2:Other Arg | De novo or dominant inherited | MMIHS or CIPO. Severity range and more moderate or mild cases than groups above | Moderate rates of mortality and transplantation |
Non-Arg ACTG2 | De novo or dominant inherited | MMIHS or CIPO. Severity range and more moderate or mild cases than groups above | Moderate to high rates of mortality and transplantation |
ACTG2-negative | Sporadic or ultra-rare recessive | Less severe as a group than ACTG2 positive, but some severe cases | Low rates of mortality and transplantation |
Abbreviations: CIPO, chronic intestinal pseudo-obstruction; MMIHS, megacystis-microcolon intestinal hypoperistalsis syndrome